Pharmaceuticals

Nausea Medicine Market Size Forecast: Revenue and CAGR by 2029

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The Nausea Medicine Industry Expected To Reach By 2029, Starting From 2025 Levels?

The nausea medicine market has experienced substantial expansion in recent years. Its value is anticipated to climb from $3.02 billion in 2024 to $3.22 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.5%. The market’s growth in the past can be ascribed to a rise in chemotherapy instances, increased recognition of pregnancy-related nausea (NVP), an uptick in surgical procedures, greater awareness of motion sickness, the widespread occurrence of chronic gastrointestinal disorders, and the development of pediatric formulations.

The nausea medicine market is projected to experience substantial expansion in the coming years, reaching $4.21 billion by 2029, with a compound annual growth rate (CAGR) of 7.0%. This anticipated growth during the forecast period is due to factors such as increased penetration of cancer treatments, a regulatory drive for safer components, the broadening use of telehealth and e-prescriptions, the rise in minimally invasive surgical procedures, and enhancements in hospital infrastructure. Key developments anticipated within this period involve the incorporation of digital health technologies, the creation of specific targeted therapies, a movement towards individualized medical approaches, the increased use of transdermal patches for administration, and continuous progress in drug formulation techniques.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24329&type=smp

What Are The Main Drivers Boosting The Nausea Medicine Industry’s Expansion?

The increasing intake of unhealthy diets is projected to drive the expansion of the nausea medicine market in the future. An unhealthy diet involves the consumption of excessive processed foods, sugars, unhealthy fats, and salt, concurrently deficient in vital nutrients like vitamins, minerals, and fiber. This rise in unhealthy diet consumption primarily stems from the accessibility and affordability of processed and fast foods, which are more convenient than healthier alternatives. The growing intake of unhealthy diets contributes to symptoms such as gastrointestinal discomfort, indigestion, acid reflux, and nausea. Nausea medicine, including antiemetics, alleviates nausea by addressing its root causes, which can include motion sickness, gastrointestinal problems, or medication side effects. Such medications function by either blocking brain signals that induce nausea or by calming the stomach, thereby reducing the urge to vomit and offering comfort. For example, in April 2025, the American Journal of Preventive Medicine, a US-based government organization, reported that annual deaths linked to ultra-processed foods in the United States exceed 124,000. Consequently, the increase in unhealthy diets is propelling the expansion of the nausea medicine market.

What Are The Primary Types Of Segments Analyzed In The Nausea Medicine Market?

The nausea medicine market covered in this report is segmented –

1) By Type: Antagonists, Antagonists, Canabinoids, Other Types

2) By Indication: Oncology, Gastroesophageal Reflux Disease, Motion Sickness and Seasickness, Other Indications

3) By Route of Administration: Oral, Injectable, Transdermal, Rectal, Other Route of Administrations

4) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Other Distribution Channels

5) By End User: Hospitals, Homecare settings, Ambulatory Surgical centres, Long-term Care Facilities, Individual Consumers

Subsegments:

1) By Antagonists: Serotonin Antagonists, Neurokinin-1 (NK1) Receptor Antagonists, Dopamine Antagonists

2) By Antihistamines: H1 Antihistamines, H2 Antihistamines

3) By Cannabinoids: THC (Tetrahydrocannabinol), CBD (Cannabidiol)

4) By Other Types: Corticosteroids, Benzodiazepines, Ginger-Based Medications

What Trends Are Redefining The Nausea Medicine Market Dynamics?

Major companies within the nausea medicine market are primarily focused on developing innovative solutions, such as chemotherapy-induced nausea medication, to improve patient outcomes and manage cases that are resistant to treatment. Chemotherapy-induced nausea medication refers to drugs specifically formulated to prevent or relieve nausea and vomiting caused by cancer chemotherapy, often by targeting serotonin or neurokinin receptors in the brain. For instance, in January 2023, Glenmark Pharmaceuticals, an India-based pharmaceutical company, introduced AKYNZEO I.V., a ready-to-dilute intravenous injection combining fosnetupitant and palonosetron, to prevent chemotherapy-induced nausea and vomiting (CINV). This single-dose intravenous medication integrates fosnetupitant and palonosetron, providing protection against both the acute and delayed phases of CINV. This single 30-minute infusion effectively covers both acute and delayed phases of CINV, thereby simplifying treatment by reducing the need for multiple antiemetic drugs and improving patient compliance.

Which Industry Leaders Are Driving Innovation Across The Nausea Medicine Market?

Major companies operating in the nausea medicine market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bayer Aktiengesellschaft, Merck & Co. Inc., Sanofi S.A., Novartis AG, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Helsinn Healthcare SA, Mylan N.V., Viatris Inc., Baxter International Inc., Teva Pharmaceutical Industries Limited, Sun Pharmaceutical Industries Limited, Zydus Lifesciences Limited, Amneal Pharmaceuticals Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/nausea-medicine-global-market-report

What Regional Growth Trends Are Shaping The Nausea Medicine Market Outlook?

North America was the largest region in the nausea medicine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nausea medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Nausea Medicine Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24329&type=smp

Browse Through More Reports Similar to the Global Nausea Medicine Market 2025, By The Business Research Company

Chemotherapy Induced Nausea And Vomiting Cinv Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/chemotherapy-induced-nausea-and-vomiting-cinv-global-market-report

Cell Regeneration Medicine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cell-regeneration-medicine-global-market-report

Herbal Medicine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/herbal-medicine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795